GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,512 Cr | ₹2,572 Cr | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹2,512 Cr |
| Mar2025 | ₹2,572 Cr |
| Mar2024 | ₹2,545 Cr |
| Mar2023 | ₹2,447 Cr |
| Mar2022 | ₹2,516 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,512 Cr | -2.31 | |
| Mar2025 | ₹2,572 Cr | 1.05 | |
| Mar2024 | ₹2,545 Cr | 3.99 | |
| Mar2023 | ₹2,447 Cr | -2.73 | |
| Mar2022 | ₹2,516 Cr | - | |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,921.8 Cr | -1.3% | 0.2% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.3% |
0.2% |
-6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses